TRIL - Trillium Therapeutics Inc
Previous close
18.44
0 0%
Share volume: 0
Last Updated: Tue 16 Nov 2021 06:00:00 AM CET
Biological Product (except Diagnostic) Manufacturing :
-3.41%
PREVIOUS CLOSE
CHG
CHG%
$18.44
0.00
0.00%
Summary score
42%
Profitability
45%
Dept financing
25%
Liquidity
49%
Performance
42%
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-24.85%
Return on assets
-15.84%
Return on sales
0%
Return on invested capital
71.6%
Total debt ratio
22.87%
Debt ratio change over timeo
-0.94%
Current Ratio
6.26%
Quick Ratio
0%
Cash Position Ratio
2.75%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-63.74%
Return on assets
-14.62%
Return on sales
0%
Return on invested capital
347.33%
Total debt ratio
44.01%
Debt ratio change over timeo
-0.62%
Current Ratio
7.55%
Quick Ratio
0%
Cash Position Ratio
3.97%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-76.25%
Return on assets
-5.45%
Return on sales
0%
Return on invested capital
581.49%
Total debt ratio
49.14%
Debt ratio change over time
-0.57%
Current Ratio
12.44%
Quick Ratio
0%
Cash Position Ratio
6.79%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-107.44%
Return on assets
-101.18%
Return on sales
0%
Return on invested capital
47.39%
Total debt ratio
-93.58%
Debt ratio change over time
-0.94%
Current Ratio
-1.19%
Quick Ratio
0%
Cash Position Ratio
-1.22%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | TRIL | SGEN | NK | SRNG |
|---|---|---|---|---|
| Return on equity | -24.85% | -4.61% | -11.83% | 0% |
| Return on assets | -15.84% | -4.6% | -10.3% | 0% |
| Return on sales | 0% | -37.29% | 0% | 0% |
| Return on invested capital | 71.6% | 265.33% | -27.14% | 0% |
| Profitability | 32% | 25% | 0% | 50% |
| Total debt ratio | 22.87% | 18.22% | 14.3% | 0% |
| Debt ratio change over time | -0.94% | -1.66% | -1.56% | 0% |
| Dept financing | 25% | 20% | 16% | 25% |
| Current Ratio | 7.55% | 4.65% | 5.1% | 0% |
| Quick Ratio | 0% | 4.32% | 0% | 0% |
| Cash Position Ratio | 3.97% | 0.81% | 2.5% | 0% |
| Liquididy | 46% | 46% | 38% | 0% |
| Short-term ratios | TRIL | SGEN | NK | SRNG |
|---|---|---|---|---|
| Return on equity | -63.74% | -3.62% | -13.55% | 0% |
| Return on assets | -14.62% | -3.93% | -11.56% | 0% |
| Return on sales | 0% | -34.27% | 0% | 0% |
| Return on invested capital | 347.33% | -9.88% | -24.84% | 0% |
| Profitability | 50% | 0% | 0% | 50% |
| Total debt ratio | 44.01% | 15.47% | 15.89% | 0% |
| Debt ratio change over time | -0.62% | -0.59% | -1.72% | 0% |
| Dept financing | 25% | 9% | 9% | 25% |
| Current Ratio | 7.55% | 4.65% | 5.1% | 0% |
| Quick Ratio | 0% | 4.32% | 0% | 0% |
| Cash Position Ratio | 3.97% | 0.81% | 2.5% | 0% |
| Liquididy | 50% | 45% | 33% | 0% |